Patents Assigned to NLS Pharma AG
  • Use of iron for treating attention deficit hyperactivity disorder in children
    Patent number: 10532100
    Abstract: The invention relates to the use of iron for preparing a medicament for the preventive and/or curative treatment of attention deficit hyperactivity disorder (ADHD) or at least one of the symptoms thereof, for a patient requiring such treatment.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: January 14, 2020
    Assignee: NLS PHARMA AG
    Inventor: Eric Konofal
  • Lauflumide and the enantiomers thereof, method for preparing same and therapeutic uses thereof
    Patent number: 9637447
    Abstract: The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: May 2, 2017
    Assignee: NLS Pharma AG
    Inventor: Eric Konofal